Сравнение диагностической ценности диффузионно-взвешенной магнитно-резонансной томографии, позитронно-эмиссионной томографии с 18F-ФДГ и компьютерной томографии всего тела при метастатическом раке молочной железы
Аннотация
Об авторах
П. Б. ГележеРоссия
С. П. Морозов
Россия
Список литературы
1. Dresen R., De Vuysere S., De Keyzer F. et al. Whole-body diffusion-weighted MRI for operability assessment in patients with colorectal cancer and peritoneal metastases // Cancer Imag. 2019. № 19:1.
2. Han S., Amant F., Michielsen K. et al. Feasibility of whole body diffusion-weighted MRI for detection of primary tumour, nodal and distant metastases in women with cancer during pregnancy: a pilot study // J. Magn. Reson. Imag. 2017. № 46 (6). P. 1707-1717.
3. Heusner T., Kuemmel S., Koeninger A. et al. Diagnostic value of diffusion-weighted magnetic resonance imaging (DWI compared to FDG PET/CT for whole-body breast cancer staging // Eur. J. of Nucl. Med. and Mol. Imag. 2010. № 6. P. 1077-1086.
4. Jung N., Kim H., Jung J. et al. Restaging the axilla after neo-adjuvant chemotherapy for breast cancer: Predictive factors for residual metastatic lymph node disease with negative imaging findings // Breast J. 2019. № 25 (2). P. 196-201.
5. Kitajima K., Yamano T., Miyoshi Yu. et al. Prognostic value of 18F-FDG PET/CT prior to breast cancer treatment. Comparison with magnetic resonance spectroscopy and diffusion weighted imaging // Hell. J. Nucl. Med. 2019. № 22(1). P. 25-35.
6. Kosmin M., Priya V., Mei-Lin A. et al. The addition of whole body magnetic resonance imaging to body computerised tomography alters treatment decisions in patients with metastatic breast cancer // Eur. J. of Cancer. № 77. P. 109-116.
7. Kwee T., Takahara T., Ochiai R. et al. Whole body diffusion-weighted magnetic resonance imaging // Eur. J. Radiol. 2009. № 70 (3). P. 409-417.
8. Li B., Li Q., Nie W. et al. Diagnostic value of whole body diffusion-weighted magnetic resonance imaging for detection of primary and metastatic malignancies: a meta-analysis // Eur. J. Radiol. 2014. № 83 (2). P. 338-344.
9. Liu B., Gao S., Li S. A. Comprehensive comparison of CT, MRI, positron emission tomography or positron emission tomography/CT, and diffusion weighted imaging-MRI for detecting the lymph nodes metastases in patients with cervical cancer: a meta-analysis based on 67 studies // Gynecol. Obstet. Invest. 2017. № 82 (3). P. 209-222.
10. Morone M., Bali M., Tunariu N. et al. Whole body MRI: current applications in oncology // Am. J. Roentgenol. 2017. № 209(6). P. 336-349.
11. Ohno Y., Yoshikawa T., Kishida Y. et al. Diagnostic performance of different imaging modalities in the assessment of distant metastasis and local recurrence of tumor in patients with non-small cell lung cancer // Eur. Radiol. 2018. № 28 (5). P. 1862-1874.
12. Orsaria P., Chiaravalloti A., Caredda E. et al. Evaluation of the usefulness of FDG-PET/CT for nodal staging of breast cancer // Anticancer Res. 2018. № 38 (12). P. 6639-6652.
13. Paruthikunnan S., Kadavigere R., Karegowda L. Accuracy of whole-body dwi for metastases screening in a diverse group of malignancies: comparison with conventional cross-sectional imaging and nuclear scintigraphy // Am. J. Roentgenol. 2017. № 209 (3). P. 477-490.
14. Rezk M., Nasr I., Ali I. et al. Comparative study between 18F FDG-PET/CT and whole body MRI DWIBS in assessment of recurrent breast cancer (prospective, comparative, cross-sectional study design // Ind. J. of Nucl. Med. 2019. № 34 (1). P. 1-9.
15. Schaarschmidt B., Buchbender C., Nensa F. et al. Correlation of the apparent diffusion coefficient (ADC. with the standardized uptake value (SUV in lymph node metastases of non-small cell lung cancer (NSCLC. patients using hybrid 18F-FDG PET/MRI // PLoS One. 2015. № 10 (1). P. 1-14.
16. Shen G., Ma H., Liu B. et al. Diagnostic Performance of DWI with multiple parameters for assessment and characterization of pulmonary lesions: a meta-analysis // Am. J. of Roentgenol. 2017. № 210. P. 1-10.
17. Xing H., Song C., Li W. Meta-analysis of lymph node metastasis of breast cancer patients: Clinical value of DWI and ADC value // Eur. J. Radiol. 2016. № 85 (60). P. 1132-1137.
Рецензия
Для цитирования:
Гележе П.Б., Морозов С.П. Сравнение диагностической ценности диффузионно-взвешенной магнитно-резонансной томографии, позитронно-эмиссионной томографии с 18F-ФДГ и компьютерной томографии всего тела при метастатическом раке молочной железы. Радиология — практика. 2019;(6):8-20.
For citation:
Gelezhe P.B., Morozov S.P. Comparison of the Diagnostic Value of Whole-body MRI with Diffusion-weighted Images, 18F-FDG Positron Emission Tomography Combined with Computer Tomography and Whole Body Computer Tomography in Metastatic Breast Cancer. Radiology - Practice. 2019;(6):8-20. (In Russ.)